Full View

Treatment of nonalcoholic fatty liver disease: role of AMPK

BK Smith, K Marcinko, EM Desjardins… - American Journal …, 2016 - journals.physiology.org
Nonalcoholic fatty liver disease (NAFLD) is a growing worldwide epidemic and an important
risk factor for the development of insulin resistance, type 2 diabetes, nonalcoholic …
被引用次数：447 相关文章

Treatment of nonalcoholic fatty liver disease: role of AMPK

BK Smith, K Marcinko, EM Desjardins, JS Lally… - American Journal of …, 2016 - cir.nii.ac.jp
抄録< jats: p> Nonalcoholic fatty liver disease (NAFLD) is a growing worldwide epidemic
and an important risk factor for the development of insulin resistance, type 2 diabetes …

Treatment of nonalcoholic fatty liver disease: role of AMPK

BK Smith, K Marcinko… - American journal …, 2016 - pubmed.ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is a growing worldwide epidemic and an important
risk factor for the development of insulin resistance, type 2 diabetes, nonalcoholic …
[PDF] archive.org

[PDF][PDF] Treatment of nonalcoholic fatty liver disease: role of AMPK

BK Smith, K Marcinko, EM Desjardins… - Am J Physiol …, 2016 - scholar.archive.org
Treatment of nonalcoholic fatty liver disease: role of AMPK. Am J Physiol Endocrinol Metab
311: E730–E740, 2016. First published August 30, 2016; doi: 10.1152/ajpendo …

Treatment of nonalcoholic fatty liver disease: role of AMPK.

BK Smith, K Marcinko, EM Desjardins… - American Journal of …, 2016 - europepmc.org
Nonalcoholic fatty liver disease (NAFLD) is a growing worldwide epidemic and an important
risk factor for the development of insulin resistance, type 2 diabetes, nonalcoholic …
[PDF] researchgate.net

[PDF][PDF] Treatment of nonalcoholic fatty liver disease: role of AMPK

BK Smith, K Marcinko, EM Desjardins… - Am J Physiol …, 2016 - researchgate.net
Treatment of nonalcoholic fatty liver disease: role of AMPK. Am J Physiol Endocrinol Metab
311: E730–E740, 2016. First published August 30, 2016; doi: 10.1152/ajpendo …